Halozyme Therapeutics (HALO) Current Deferred Revenue (2010 - 2023)
Halozyme Therapeutics (HALO) posted Current Deferred Revenue of $667,000 for Q3 2023, down 81.4% from $3.59 million a year earlier and down 20.8% from the prior quarter.
Powered by 
Analysis
Halozyme Therapeutics (HALO) Current Deferred Revenue (2010 - 2023) Analysis & Trends
At the end of FY2022, Halozyme Therapeutics' Current Deferred Revenue came in at $3.25 million, up 85.9% from FY2021.
- Annual Current Deferred Revenue shows a five-year compound annual growth rate of -13.1% (FY2017 to FY2022).
- In prior years, Halozyme Therapeutics' Current Deferred Revenue was $1.75 million in FY2021 (unchanged), $1.75 million in FY2020 (-56.5%), $4.01 million in FY2019 (-5.5%) and $4.25 million in FY2018 (-35.3%).
- The Q3 2023 figure stands as the lowest quarterly Current Deferred Revenue in data going back to Q4 2010.
- On a year-over-year basis, Current Deferred Revenue increased in four of the last eight quarters, with growth averaging 37.7%.
- The strongest year-over-year quarter for Current Deferred Revenue in the past five years was Q1 2019, with growth of 240.6%; the weakest was Q2 2020, with a decline of 88.5%.
- According to Business Quant data, Current Deferred Revenue for the three prior quarters was $842,000 (Q2 2023), $3.25 million (Q1 2023) and $3.25 million (Q4 2022).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | Halozyme Therapeutics | 12.59 Bn | 11.20 Bn | 401.83 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2023 | 667,000.00 |
| Jun 30, 2023 | 842,000.00 |
| Mar 31, 2023 | 3.25 Mn |
| Dec 31, 2022 | 3.25 Mn |
| Sep 30, 2022 | 3.59 Mn |
| Jun 30, 2022 | 4.13 Mn |
| Mar 31, 2022 | 1.75 Mn |
| Dec 31, 2021 | 1.75 Mn |
| Sep 30, 2021 | 2.25 Mn |
| Jun 30, 2021 | 1.25 Mn |
| Mar 31, 2021 | 1.75 Mn |
| Dec 31, 2020 | 1.75 Mn |
| Sep 30, 2020 | 748,000.00 |
| Jun 30, 2020 | 748,000.00 |
| Mar 31, 2020 | 4.01 Mn |
| Dec 31, 2019 | 4.01 Mn |
| Sep 30, 2019 | 3.51 Mn |
| Jun 30, 2019 | 6.51 Mn |
| Mar 31, 2019 | 4.25 Mn |
| Dec 31, 2018 | 4.25 Mn |
API Access
Halozyme Therapeutics Current Deferred Revenue API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HALO&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-deferred-revenue", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=current-deferred-revenue&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();